financetom
Business
financetom
/
Business
/
Kilroy Realty Q2 FFO, Revenue Rise; Updates 2025 Outlook
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Kilroy Realty Q2 FFO, Revenue Rise; Updates 2025 Outlook
Jul 28, 2025 2:08 PM

04:51 PM EDT, 07/28/2025 (MT Newswires) -- Kilroy Realty ( KRC ) reported Q2 funds from operations late Monday of $1.13 per diluted share, up from $1.10 a year earlier.

Analysts polled by FactSet expected $0.99.

Revenue in the three months ended June 30 rose to $289.9 million from $280.7 million a year earlier.

Analysts surveyed by FactSet expected $269.9 million.

The company raised the 2025 Nareit funds from operations outlook to $4.05 to $4.15 a share, from $3.85 to $4.05 previously.

Analysts polled by FactSet expect $3.95.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Analysis-Boom to bust: Beyond Meat struggles to stay relevant
Analysis-Boom to bust: Beyond Meat struggles to stay relevant
Oct 23, 2025
(Reuters) -Once a Wall Street darling worth roughly $14 billion, Beyond Meat ( BYND ) is now a meme stock. While the company's decline started after the pandemic when rising inflation made its expensive products unattractive, a consumer shift toward healthier foods amid the Make America Healthy Again movement and the rise of weight-loss drugs expedited its demise. There have...
Dow posts smaller-than-expected quarterly loss on lower costs, resilient demand
Dow posts smaller-than-expected quarterly loss on lower costs, resilient demand
Oct 23, 2025
Oct 23 (Reuters) - Chemicals company Dow Inc ( DOW ) posted a smaller-than-expected adjusted quarterly loss in the third quarter on Thursday, helped by lower costs, higher volumes from new U.S. Gulf Coast assets, and stronger demand in industrial markets, even as global chemical prices remained weak. Shares of Dow were up 1.4% at $22.00 in premarket trading. Chemical...
West Pharmaceutical beats Q3 net sales estimates; lifts FY revenue, EPS outlook
West Pharmaceutical beats Q3 net sales estimates; lifts FY revenue, EPS outlook
Oct 23, 2025
Overview * West Pharmaceutical Services ( WST ) Q3 net sales up 7.7%, beating analyst expectations * Adjusted EPS for Q3 beats consensus, reflecting strong operational performance * Company raises full-year 2025 revenue and EPS guidance, citing ongoing momentum Outlook * West Pharmaceutical raises full-year 2025 revenue guidance to $3.060 bln-$3.070 bln * Company increases full-year 2025 adjusted EPS guidance...
Materials science company Dow misses Q3 net sales estimates
Materials science company Dow misses Q3 net sales estimates
Oct 23, 2025
Overview * Dow Q3 net sales fell 8% yr/yr, missing analysts' expectations * Adjusted EPS for Q3 beats consensus despite a yr/yr decline * Company achieved sequential EBIT growth through cost reductions and operational improvements Outlook * Dow aims to deliver over $6.5 bln in near-term cash support * Company focuses on resilient portfolio areas to capture market share and...
Copyright 2023-2026 - www.financetom.com All Rights Reserved